Severe strongyloidiasis in corticosteroid-treated patients

被引:61
|
作者
Fardet, L. [1 ]
Genereau, T. [1 ]
Kettaneh, A. [1 ]
机构
[1] Hop St Antoine, Dept Internal Med, F-75012 Paris, France
关键词
corticosteroids; diagnosis; ivermectine; Strongyloides stercoralis; treatment;
D O I
10.1111/j.1469-0691.2006.01443.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Severe strongyloidiasis, caused by Strongyloides stercoralis, is a preventable life-threatening disease that can occur in any corticosteroid-treated patient who has travelled to a country with infested soil, even if the contact occurred up to 30 years previously. This diagnosis should be considered in corticosteroid-treated patients who experience either unusual gastrointestinal or pulmonary symptoms, or who suffer from unexplained sepsis caused by Gram-negative bacilli. Peripheral eosinophilia is not observed systematically and, even if present, is moderate in most cases. Ivermectine is the best prophylactic and therapeutic option, and thiabendazole should no longer be used. However, guidelines for the prevention and management of S. stercoralis infection in such patients have not yet been established.
引用
收藏
页码:945 / 947
页数:3
相关论文
共 50 条
  • [1] Severe strongyloidiasis in corticosteroid-treated patients:: Case series and literature review
    Fardet, Laurence
    Genereau, Thierry
    Poirot, Jean-Louis
    Guidet, Bertrand
    Kettaneh, Adrien
    Cabane, Jean
    [J]. JOURNAL OF INFECTION, 2007, 54 (01) : 18 - 27
  • [2] rhGH treatment in corticosteroid-treated patients
    Simon, Dominique
    [J]. HORMONE RESEARCH, 2007, 68 (01) : 38 - 45
  • [3] Leishmania infantum leishmaniasis in corticosteroid-treated patients
    Pittalis, Silvia
    Nicastri, Emanuele
    Spinazzola, Francesco
    Ghirga, Piero
    De Marco, Michele
    Paglia, Maria Grazia
    Narciso, Pasquale
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [4] TUBERCULOSIS IN CORTICOSTEROID-TREATED ASTHMATICS
    不详
    [J]. BRITISH MEDICAL JOURNAL, 1976, 2 (6030): : 266 - 267
  • [5] Discrimination between oral corticosteroid-treated and oral corticosteroid-non-treated severe asthma patients by an electronic nose platform
    Santini, Giuseppe
    Di Carlo, Stefano
    Benso, Alfredo
    Mores, Nadia
    Brinkman, Paul
    Valente, Salvatore
    Montuschi, Paolo
    Macagno, Francesco
    Wagener, Ariane H.
    Bansal, Aruna T.
    Pandis, Ioannis
    Knobel, Hugo H.
    Vink, Anton J.
    Rattray, Nicholas
    Santonico, Marco
    Pennazza, Giorgio
    Guo, Yi-Ke
    Horvath, Ildiko
    Djukanovic, Ratko
    Polosa, Riccardo
    Sousa, Ana R.
    Corfield, Julie
    Rowe, Anthony
    Fowler, Stephen J.
    Chanez, Pascal
    Chung, Kian Fan
    Sterk, Pater J.
    Montuschi, Paolo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [6] PATHOLOGY OF CORTICOSTEROID-TREATED ASTHMA
    KEENEY, EL
    PALMER, LA
    [J]. JOURNAL OF ALLERGY, 1965, 36 (02): : 97 - &
  • [7] Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients
    Brown, E. Sherwood
    Zaidel, Liam
    Allen, Greg
    McColl, Roderick
    Vazquez, Miguel
    Ringe, Wendy K.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2010, 126 (03) : 415 - 419
  • [8] Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS.
    Vandersmissen, G
    Meuleman, L
    Tits, G
    Verhaeghe, A
    Peetermans, WE
    [J]. ACTA CLINICA BELGICA, 1996, 51 (02): : 111 - 117
  • [9] SERUM ZINC LEVELS IN CORTICOSTEROID-TREATED ASTHMATIC-PATIENTS
    ELLULMICALLEE, R
    FENECH, FF
    GALDES, A
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (605) : 148 - 150
  • [10] OSTEOPOROSIS IN CORTICOSTEROID-TREATED ASTHMATIC-PATIENTS - CLINICAL CORRELATES
    SCHATZ, M
    DUDL, J
    ZEIGER, RS
    HARDEN, K
    CHILINGAR, L
    FORSYTHE, A
    BAYLINK, DJ
    [J]. ALLERGY PROCEEDINGS, 1993, 14 (05): : 341 - 345